The Team
LEADERSHIP
MANAGEMENT
Developed machine learning and quantum technology
25+ years quantum molecular modeling in pharmaceuticals, diagnostics & imaging
Florida State University, Rensselaer Polytechnic Institute
Lyubomir Nashev PhD
Research Director
PhD Biochemistry and Molecular medicine
Post-doc Pharmacetrum, University of Basle
Metalife AG
COO & CFO
Over twenty years in corporate finance in technology and energy sectors
Extensive experience in capital raises, financial planning, and project management
MBA from Rutgers University in Finance and Marketing
Max Duckworth
Board, Lead Investor
Investor-director with broad experience in drugs, diagnostics and devices
Former energy executive with M&A experience
B.Sc (Hons) Imperial College & MA Boston University, in Physics
BOARD/ADVISOR
Ravi Nargund PhD
Progressed 25 clinical candidates, including multiple compounds through Phase 1b/2a/2b/3 studies for various therapeutic indications
PhD Organic Chemistry, 60 issued U.S. patents, 115 publications
Erik Halvorsen PhD
Board
20 years commercializing healthcare technology
Past board member for Tetraphase, Claritas Genomics and Jibo
Partner, PH Partners healthcare investment bank
Srinivas Kasibhatla PhD
Medicinal Chemistry
25+ years drug discovery; Gensia/Metabasis, Biogen Idec, BMS
Contributed to discovery of 9 clinical candidates
Ph.D. at UH, Hyderabad and Postdoc at Harvard University
Stephen Horrigan PhD
Cancer Biology
CSO, Noble Life Sciences
VP of Research at Avalon Pharma
Associate Professor, Georgetown University
Eugene Cordes PhD
Senior Advisor
VP, Biochemistry & Molecular Biology, Merck
Professor Emeritus of Chemistry, Indiana University
More than 120 peer-reviewed publications